000 | 01111 a2200253 4500 | ||
---|---|---|---|
005 | 20250514074939.0 | ||
264 | 0 | _c20040513 | |
008 | 200405s 0 0 eng d | ||
022 | _a1096-6374 | ||
024 | 7 |
_a10.1016/s1096-6374(03)00065-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlibanski, Anne | |
245 | 0 | 0 |
_aGrowth hormone and cardiovascular risk markers. _h[electronic resource] |
260 |
_bGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _cAug 2003 |
||
300 |
_aS109-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
650 | 0 | 4 |
_aGrowth Hormone _xdeficiency |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypopituitarism _xcomplications |
650 | 0 | 4 | _aRisk Factors |
773 | 0 |
_tGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _gvol. 13 Suppl A _gp. S109-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1096-6374(03)00065-0 _zAvailable from publisher's website |
999 |
_c12688090 _d12688090 |